Mesenchymal stem cells: A therapeutic update;Les cellules souches mésenchymateuses: Actualités thérapeutiques

Medecine/Sciences

Volumn 27, Issue 3, 2011, Pages 275-284

  Jorgensen, Christian ^a   Deschaseaux, Frédéric ^b   Planat Benard, Valérie ^b   Gabison, Éric ^c  

^a INSERM   (France)

^b CNRS   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE REGENERATION; CARDIOVASCULAR DISEASE; EYE DISEASE; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; REGENERATION;

BONE REGENERATION; CARDIOVASCULAR DISEASES; EYE DISEASES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; REGENERATION;

EID: 79955042207     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2011273275     Document Type: Article

References (88)

1. Liang J, Zhang H, Hua B, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 2010 ; 69 :1423-9.
2. Carrion F, Nova E, Ruiz C, et al. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus 2010 ; 19 : 317-22.
3. Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005 ; 106:1755-61.
4. Karussis D, Karageorgiou C, Vakmn-Dembinsky A, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010 ; 67 :1187-94.
5. Yamout B, Hourani R, Salti H, et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study J Neuroimmunol 2010;227:185-9.
6. Garcia-Olmo D, Herreros D, Pascual I, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase Il clinical trial. Dis Colon Rectum 2009 ; 52 : 79-86.
7. Augello A, Tasso R, Negrini SM, et al. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007 ; 56 :1175-86. (Pubitemid 46608642)
8. Djouad F, Fritz V, Apparailly F, et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005 ; 52 :1595-1603. (Pubitemid 40663952)
9. Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg 1994 ; 76A : 579-92 (Pubitemid 24154130)
10. Caplan Al, Elyaderani M, Mochizuki y, et al. Principles of cartilage repair and regeneration. Clin Orthopaedics Related Res 1997 ; 342 : 254-69. (Pubitemid 27400825)
11. Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003 ; 48 : 3464-74. (Pubitemid 37531912)
12. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004 ; 363 :1 439-41.
13. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study Lancet 2008 ; 371:1579-86. (Pubitemid 351626841)
14. Deschaseaux F, Pontikoglou C, Sensebe L. Bone regeneration: the stem/ progenitor cells point of view J Cell Mol Med 2010; 14:103-15.
15. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999 ; 284:143-7. (Pubitemid 29282067)
16. Morikawa S, Mabuchi Y, Kubota Y, et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 2009 ; 206 : 2483-96.
17. Connolly J, Guse R, Lippiello L, Dehne R. Development of an osteogenic bone-marrow preparation. J Bone Joint Surg Am 1989 ; 71: 684-91.
18. Connolly JF, Guse R, Tiedeman J, Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 1991;256:259-70.
19. Healey JH, Zimmerman PA, McDonnell JM, Lane JM. Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Orthop Relat Res 1990 ; 256 : 280-5.
20. Hernigou P, Beaujean F. Pseudarthrosis treated by percutaneous autologous bone marrow graft. Rev Chir Orthop Reparatrice Appar Mot 1997 ; 83:495-504. (Pubitemid 27465788)
21. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.y Bone Joint Surg Am 2005 ; 87 :1430-7. (Pubitemid 40917741)
22. Sensebe L, Bourin P. Mesenchymal stem cells for therapeutic purposes. Transplantation 2009 ; 87: S49-53.
23. Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99: 8932-7. (Pubitemid 34693661)
24. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999 ; 5 : 309-13. (Pubitemid 29124367)
25. Le Blanc K, Gotherstrom C, Ringden O, et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005 ; 79:1607-14. (Pubitemid 40847594)
26. Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001 ; 344: 385-6. (Pubitemid 32107654)
27. Warnke PH, Springer IN, Wiltfang J, et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 2004 ; 364 : 766-70.
28. Yamada Y, Ueda M, Hibi H, Baba S. A novel approach to periodontal tissue regeneration with mesenchymal stem cells and platelet-rich plasma using tissue engineering technology: A clinical case report. Int J Periodontics Restorative Dent 2006 ; 26: 363-9. (Pubitemid 44220381)
29. Hibi H, Yamada Y, Ueda M, Endo y. Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int J Oral Maxillofac Surg 2006 ; 35: 551-5.
30. Kitoh H, Kitakoji T, Tsuchiya H, et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis: a preliminary result of three cases. Bone 2004 ; 35: 892-8. (Pubitemid 39349220)
31. Morishita T, Honoki K, Ohgushi H, et al. Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 2006 ; 30 :115-8.
32. Sensebé L, Bourin P. Cellules souches mésenchymateuses : production à usage clinique et contraintes sécuritaires. Med Sci (Paris) 2011 ; 27 : 297-302.
33. Vinatier C, Bordenave L, Guicheux J, Amédée J. Les cellules souches en ingénierie des tissus ostéoarticulaires et vasculaires. Med Sci (Paris) 2011 ; 27:289-96.
34. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J CIm Invest 1999 ; 103: 697-705. (Pubitemid 29122423)
35. Rangappa S, Fen C, Lee EH, et al. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 2003;75:775-9. (Pubitemid 36298339)
36. Li H, Yu B, Zhang Y, et al. Jaggedl protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. Biochem Biophys Res Commun 2006 ; 341: 320-5. (Pubitemid 43152109)
37. Wang T, Xu Z, Jiang W, et al. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol 2006 ; 109 :74-81.
38. Arminan A, Gandia C, Bartual M, et al. Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. Stem Cells Dev 2009 ; 18:907-18.
39. Wang T, Xu Z, Jiang W, et al. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol 2006 ; 109 : 74-81.
40. Zhu Y, Liu T, Song K, et al. ADSCs differentiated into cardiomyocytes in cardiac microenvironment. Mol Cell Biochem 2009 ; 324:117-29.
41. Rose RA, Jiang H, Wang X, et al. Bone marrow-derived mesenchymal stromal cells express cardiacspecific markers, retain the stromal phenotype and do not become functional cardiomyocytes in vitro. Stem Cells 2008 ; 26 : 2884-92.
42. Grauss RW, Winter EM, van Tuyn J, et al. Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction. Am J Physiol Heart Cm Physiol 2007 ; 293 : H2438-47.
43. Berry MF, Engler AJ, Woo YJ, et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. AmJ Physiol Heart Circ Physiol 2006 ; 290 : H2196-2203.
44. Jaquet K, Krause KT, Denschel J, et al. Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism? Stem Cells Dev 2005 ; 14:299-309. (Pubitemid 40885254)
45. Valina C, Pinkernell K, Song YH, et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 2007 ; 28 : 2667-77.
46. Cai L, Johnstone BH, Cook TG, et al. IFATS collection: human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells 2009 ; 27 : 230-7.
47. Noiseux N, Gnecchi M, Lopez-llasaca M, et al. Mesenchymal stem cells overexpressing akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 2006 ; 14 : 840-50. (Pubitemid 44752717)
48. Mazo M, Planat-Benard V, Abizanda G, et al. Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. EurJ Heart Fail 2008; 10:454-62.
49. Caplan Al, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006 ; 98:1076-84. (Pubitemid 44128350)
50. Pak HN, Qayyum M, Kim DT, et al. Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial Infarction. J Cardiovasc Electrophysiol 2003 ; 14 : 841-8. (Pubitemid 36994105)
51. Oswald J, Boxberger S, Jargensen B, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004 ; 22: 377-84. (Pubitemid 38736621)
52. Planat-Benard V, Silvestre JS, Cousin B, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004 ; 109:656-63. (Pubitemid 38198874)
53. Miranville A, Heeschen C, Sengenes C, et al. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004 ; 110 : 349-55. (Pubitemid 38955505)
54. Quevedo HC, Hatzistergos KE, Oskouei BN, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilmeage differentiating capacity Proc Natl Acad Sci USA 2009 ; 106 :14022-7.
55. Feygin J, Mansoor A, Eckman P, et al. Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation. Am J Physiol Heart Circ Physiol 2007; 293 : H1772-80.
56. Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptatic factors by human adipose stromal cells. Circulation 2004 ; 109:1292-8. (Pubitemid 38372789)
57. Kim Y, Kim H, Cho H, et al. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 2007 ; 20 : 867-76. (Pubitemid 350059730)
58. Charbord P, Casteilla L La biologie des cellules souches mésenchymateuses d'origine humaine. Med Sci (Paris) 2011; 27: 261-8.
59. Ménard C, Tarte K. Immunosuppression et cellules souches mésenchymateuses : mieux comprendre une propriété thérapeutique majeure. Wed Sci (Paris) 2011 ; 27:269-74.
60. Sensebé L, Bourin P.Cellules souches mésenchymateuses : production à usage clinique et contraintes sécuritaires. Med Sci (Paris) 2011 ; 27: 297-302.
61. Pellegrini G, Traverso CE, Franzi AT, et al. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 1997;349:990-3. (Pubitemid 27149803)
62. Tsai RJ, Li LM, Chen JK Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 2000 ; 343:86-93. (Pubitemid 30451851)
63. Nishida K, Yamato M, Hayashida Y, et al. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med 2004:351:1187-96. (Pubitemid 39296306)
64. Zhang X, Sun H, Li X, Yuan X, et al. Utilization of human limbal mesenchymal cells as feeder layers for human limbal stem cells cultured on amniotic membrane. J Tissue Eng Regen Med 2010 ; 4:38-44.
65. Reinshagen H, Auw-Haedrich C, Sorg RV, et al. Corneal surface reconstruction using adult mesenchymal stem cells in experimental limbal stem cell deficiency in rabbits. Acta Ophthalmol 2011 (sous presse).
66. Watson SL, Marcai H, Sarris M, et al. The effect of mesenchymal stem cell conditioned media on corneal stromal fibroblast wound healing activities. Br J Ophthalmol 2010 ; 94 :1067-73.
67. Ye J, Yao K, Kim JC. Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: engraftment and involvement in wound healing. Eye (Load) 2006 ; 20 : 482-90.
68. Gabison EE, Zhang X, Huet E, et al. Therapeutic potential of bone marrow mesenchymal stem cells in corneal chemical burns: An in vitro and in vivo study. Invest Ophthalmol Vis Sci 2009 ; 50 : 3067.
69. Choong PF, Mok PL, Cheong SK, et al. Mesenchymal stromal cell-like characteristics of corneal keratocytes. Cytotherapy 2007 ; 9 : 252-8.
70. Funderburgh ML, Du Y, Mann MM, et al. PAX6 expression identifies progenitor cells for corneal keratocytes. FASEB J 2005 ; 19 :1371-3. (Pubitemid 41113753)
71. Jiang TS, Cai L, Ji WY, et al. Reconstruction of the corneal epithelium with induced marrow mesenchymal stem cells in rats. Mol Vis 2010 ; 16 :1304-16.
72. Gu S, Xing C, Han J, et al. Differentiation of rabbit bone marrow mesenchymal stem cells into corneal epithelial cells in vivo and ex vivo. Mol Vis 2009 ; 15 : 99-107.
73. Ma Y, Xu Y, Xiao Z, et al. Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells 2006 ; 24 : 315-21. (Pubitemid 44464800)
74. Ou Y, Carlson EC, Funderburgh ML, etal. Stem cell therapy restores transparency to defective murine corneas. Stem Cells 2009 ; 27 :1635-42.
75. Arnalich-Montiel F, Pastor S, Blazquez-Martinez A, et al. Adipose-derived stem cells are a source for cell therapy of the corneal stroma. Stem Cells 2008 ; 26 : 570-9. (Pubitemid 351413618)
76. Du Y, Funderburgh ML, Mann MM, et al. Multipotent stem cells in human corneal stroma. Stem Cells 2005;23:1266-75. (Pubitemid 41504914)
77. Liu H, Zhang J, Liu CY, et al. Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice. PLoS One 2010 ; 5 : e10707.
78. Wang S, Lu B, Girman S, et al. Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology. PLoS One. 2010 ; 5 : e9200.
79. Lu B, Wang S, Girman S, et al. Human adult bone marrow-derived somatic cells rescue vision in a rodent model of retinal degeneration. Exp Eye Res 2010 ; 91:449-55.
80. Li N, Li XR, Yuan JQ. Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion. Graefes Arch Clin Exp Ophthalmol 2009 ; 247:503-14.
81. Inoue Y, Iriyama A, Ueno S, et al. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res 2007 ; 85:234-41. (Pubitemid 47087799)
82. Arnhold S, Absenger Y, Klein H, et al. Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse. Graefes Arch Clin Exp Ophthalmol 2007 ; 245 :414-22. (Pubitemid 46404003)
83. Harper MM, Adamson L, Blits B, et al. Brain-derived neurotrophic factor released from engineered mesenchymal stem cells attenuates glutamateand hydrogen peroxide-mediated death of staurosporine-differentiated RGC-5 cells. Exp Eye Res 2009 ; 89 : 538-48.
84. Johnson TV, Bull NO, Hunt DP, et al. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci 2010 ; 51:2051-9.
85. Zwart I, Hill AJ, Al-Allaf F, et al. Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model. Exp Neurol 2009 ; 216 :439-48.
86. Kicic A, Shen W, Wilson AS, et al. Differentiation of marrow stromal cells into photoreceptors in the rat eye. J Neurosa 2003 ; 23 : 7742-9. (Pubitemid 37052341)
87. Ménard C, Tarte K. Immunosuppression et cellules souches mésenchymateuses : mieux comprendre une propriété thérapeutique majeure. Med Sci (Paris) 2011 ; 27: 269-74.
88. Charbord P, Casteilla L La biologie des cellules souches mésenchymateuses d'origine humaine. Med Sci (Paris) 2011 ; 27 : 261-8.